Skip to Main Content

Paper Details

Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma.
Mol Cancer Res
5
2022
ALDH1A1, ARID2, ATPase subunit, BAF180, BAF200, BRG1, H3K4me3, Histone, PBAF complex, PBAF subunits, PBRM1, Promoter, RNA, Renal Cell Carcinoma, SNF, SWI, aldehyde, aldehyde dehydrogenase ALDH1A1, cancers, ccRCC, ccRCC cell lines, ccRCC cells, clear cell renal cell carcinoma, epigenome, histone, human, malignancies, non-malignant cells, primary tumors, retinoic acid, signaling gene signature, target gene, tumor
Author NameAffiliation
Sakellarios ZairisColumbia University
Dan HassonThe Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Emily BernsteinThe Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Raul RabadanColumbia University
  • 1 - 4

Datasets

Release 1.2